This is a non-core endpoint: only basic statistics are computed.

See these related core endpoints for full statistics:

H7_CHOROIDOTH

Other chorioretinal disorders in diseases classified elsewhere

Endpoint Browser

H7_CHORIORETOTHINOTH

No definition available.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H32.8* Cause of death: ICD-10 — H32.8* 2 out of 7 registries used, show all original rules.	13
4. Check minimum number of events None	13
5. Include endpoints None	13
6. Filter based on genotype QC (FinnGen only)	13

Control definitions (FinnGen only)

Control exclude: H7_CHOROIDRETINA

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2

NAME	H7_CHORIORETOTHINOTH
CONTROL_EXCLUDE	H7_CHOROIDRETINA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H328
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H328
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other chorioretinal disorders in diseases classified elsewhere based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	78	44	34
Only index persons	68	38	30
Unadjusted period prevalence (%)
Whole population	0.00	0.00	0.00
Only index persons	0.00	0.00	0.00
Median age at first event (years)
Whole population	-	39.41	63.30
Only index persons	49.95	39.41	63.30

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	13	7	6
Unadjusted period prevalence (%)	0.00	0.00	0.00
Median age at first event (years)	47.94	33.78	64.45

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3013512) EKG study

2.37

0.78

6.4

4.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2.37

0.78

15.6

3.3

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

2.50

0.73

2.2

3.5

2.3

2.4

mmol/l

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2.31

0.71

5.0

2.1

90.4

78.2

nmol/l

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2.31

0.71

13.2

4.6

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

2.22

0.69

6.8

3.3

—

(1761868) Lipid panel - Serum or Plasma

2.06

0.66

3.5

2.5

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

0.44

0.65

40.7

7.4

86.2

78.2

u/l

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

0.00

0.44

0.0

4.9

—

33.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

0.00

0.44

0.0

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

0.00

0.44

0.0

1.1

—

(3002256) Pathology report gross observation

0.00

0.44

0.0

1.1

—

(3035350) Ketones [Presence] in Urine by Test strip

1.56

0.26

13.2

4.2

—

0.0

—

(3021601) Nitrite [Presence] in Urine by Test strip

1.41

0.25

25.5

5.3

—

0.0

—

(3048689) Calprotectin [Mass/mass] in Stool

0.00

0.22

0.0

2.5

—

78.6

—

(3022621) pH of Urine by Test strip

0.00

0.22

0.0

1.9

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.3

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

2.3

—

0.2

—

(3017732) Neutrophils [#/volume] in Blood

0.00

0.22

0.0

2.6

—

4.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

0.00

0.22

0.0

11.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

0.00

0.22

0.0

1.0

—

(3019225) pH of Specimen

0.00

0.22

0.0

3.8

—

(3009261) Glucose [Presence] in Urine by Test strip

1.33

0.11

13.2

4.0

—

0.0

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

0.00

0.0

1.5

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

0.00

0.0

1.2

—

(40768443) Skin Pathology biopsy report

0.00

0.0

1.3

—

(40761535) Cells panel - Urine sediment

0.00

0.0

4.7

—

(3045414) Leukocytes [Presence] in Urine

0.00

0.0

1.3

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

0.00

0.0

1.5

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

0.00

0.0

1.2

—

(4035726)

0.00

0.0

1.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.00

0.0

1.5

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1.03

0.00

2.3

2.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

0.00

0.0

2.0

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

0.00

0.0

1.5

—

46.6

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.3

—

(3044889) 12 lead EKG panel

1.06

0.00

6.6

3.2

—

(3020961) Endomysium IgA Ab [Titer] in Serum

0.00

0.0

1.0

—

(3014051) Protein [Presence] in Urine by Test strip

0.00

0.0

1.4

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

0.00

0.0

1.9

—

24.0

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

0.00

0.0

2.0

—

14.0

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

0.94

0.00

5.7

3.8

15.2

14.8

pmol/l

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

0.00

0.0

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(36660697) Celiac disease serology panel - Serum

0.00

0.0

1.4

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3031040) Bacteria [#/volume] in Urine by Automated count

0.88

0.00

7.8

3.9

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

0.00

0.0

1.6

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

0.00

0.0

1.9

—

Mortality – FinRegistry

↥

Association

Association between endpoint H7_CHORIORETOTHINOTH and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have H7_CHORIORETOTHINOTH.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: H7_CHORIORETOTHINOTH – Other chorioretinal disorders in diseases classified elsewhere

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other chorioretinal disorders in diseases classified elsewhere

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints